Speaking Engagements:
Plenary: Impact of Industry Regarding the Importance of Underrepresented and Diverse Populations in Clinical Trials
Panelists:
- Diana Foster, PhD, CEO & Chief Diversity Officer, Total Diversity; Vice President of Diversity, Equity and Inclusion, SCRS
- Vivienne van de Walle, MD, PhD, CPI, CMO, Medical Director, Founder & Owner, Research Physician, PreCare Trial & Recruitment
- Ben Quartley, VP, Feasibility Recruitment and Engagement, LabCorp
The Importance of Diverse Clinical Trial Enrollment in the EU
Panelists:
- Diana Foster, PhD, CEO & Chief Diversity Officer, Total Diversity; Vice President of Diversity, Equity and Inclusion, SCRS
- Hans Christian Hoeck, MD, PhD, CEO, Trialcare Research
- Dan Milam, EMBA, Director, Clinical Trial Partnerships, EQRx
Importance of the Diversity Site Assessment Tool (DSAT) and In Relation to Best Practices in Enrolling Diverse Populations in Clinical Trials Among European Countries
Panelists:
- Amanda Rangel, MS, SVP Business Development, Total Diversity
- Brandon Doyle, MBA, Associate Director, Site Alliances, Parexel
Source : European Site Solutions Summit